4.4 Article

Antidiabetic, antioxidant, molecular docking and HPTLC analysis of miquelianin isolated from Euphorbia schimperi C. Presl

期刊

SAUDI PHARMACEUTICAL JOURNAL
卷 27, 期 5, 页码 655-663

出版社

ELSEVIER
DOI: 10.1016/j.jsps.2019.03.008

关键词

Miquelianin; Antidiabetic; Antioxidant; HPTLC; Quantification

资金

  1. Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia [RGP - 073]

向作者/读者索取更多资源

The present study demonstrates the miquelianin or quercetin 3-O-glucuronide (compound 1) isolated from aerial parts of Euphorbia schimperi exhibited significant results for antioxidant and antidiabetic potential. The compound 1 along with kaempferol 3-O-glucuronide (compound 2) and quercetin 3-O-rhamnoside (compound 3) isolated from the same source were quantified by validated HPTLC method. Antioxidant activity was determined by chemical means in terms of ABTS radical cation and DPPH radical scavenging activity. Compound 1 showed significant scavenging activity in both ABTS and DPPH assays as compared to standard BHA. In ABTS method IC50 values of compound 1 and standard BHA is found to be 58.90 +/- 3.40 mu g/mL and 28.70 +/- 5.20 mu g/mL respectively while in DPPH assay IC50 values of Compound 1 and standard BHA is 47.20 +/- 4.90 mu g/mL and 34.50 +/- 6.20 mu g/mL respectively. Antidiabetic effect was studied through alpha-amylase and alpha-glucosidase inhibitory activity. The mechanistic approach through molecular modelling also support the strong binding sites of compound 1 which showed significant alpha-amylase and alpha-glucosidase inhibitory activities with IC50 values 128.34 +/- 12.30 and 89.20 +/- 9.20 mu g/mL respectively as compared to acarbose 64.20 +/- 5.60 and 52.40 +/- 4.60 mu g/mL respectively. The results of validated RP-HPTLC analyses revealed the concentration of compound 1 found to be 16.39 mu g/mg and for compound 2 and compound 3 as 3.92 and 14.98 mu g/mg of dried extract, respectively. (C) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据